FDA clears Abbott heart attack test

The FDA grants 510(k) clearance for Abbott’s (NYSE:ABT) ARCHITECT STAT High Sensitivity Troponin-I blood test that it says will help clinicians detect heart attacks faster and more accurately than other troponin tests.

The test detects very low levels of troponin, a protein in heart muscle fibers that is released into the bloodstream when heart muscle cells are damaged.

https://seekingalpha.com/news/3501711-fda-clears-abbott-heart-attack-test